Exacerbation of Multiple Sclerosis by BRAF/MEK Treatment for Malignant Melanoma: The Central Vein Sign to Distinguish Demyelinating Lesions From Metastases

The emergence of immunomodulators as effective cancer treatments has been an important advance in cancer therapy. The combination therapy of BRAF/MEK inhibition with or without anti-CTLA-4 treatment causes an immunostimulatory effect that has greatly reduced death from melanoma. In this article, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Hemond, Christopher C., Bakshi, Rohit, Tauhid, Shahamat, Sarrosa, Rosila, Ryan, Madison, Kamath, Vineetha, Thomas, James, Edwards, Keith R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317246/
https://www.ncbi.nlm.nih.gov/pubmed/34308699
http://dx.doi.org/10.1177/23247096211033047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317246/
https://www.ncbi.nlm.nih.gov/pubmed/34308699
http://dx.doi.org/10.1177/23247096211033047

Ejemplares similares